Drug companies have a duty to continue treatment

BMJ. 1997 Mar 22;314(7084):889. doi: 10.1136/bmj.314.7084.889.
No abstract available

Publication types

  • Comment
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Developing Countries
  • Drug Industry*
  • Drugs, Investigational / supply & distribution*
  • Ethics, Medical*
  • HIV Infections / drug therapy*
  • Humans
  • Legislation, Drug
  • Social Responsibility*

Substances

  • Anti-HIV Agents
  • Drugs, Investigational